Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Mimedx (MDXG) over the last 14 years, with Q1 2025 value amounting to $135000.0.

  • Mimedx's Amortization of Deferred Charges rose 9565.22% to $135000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $464000.0, marking a year-over-year increase of 242.83%. This contributed to the annual value of $505000.0 for FY2023, which is 813.7% up from last year.
  • According to the latest figures from Q1 2025, Mimedx's Amortization of Deferred Charges is $135000.0, which was up 9565.22% from $69000.0 recorded in Q1 2024.
  • In the past 5 years, Mimedx's Amortization of Deferred Charges ranged from a high of $418000.0 in Q2 2021 and a low of $69000.0 during Q1 2024
  • In the last 5 years, Mimedx's Amortization of Deferred Charges had a median value of $120000.0 in 2022 and averaged $159357.1.
  • Data for Mimedx's Amortization of Deferred Charges shows a peak YoY increase of 10900.0% (in 2021) and a maximum YoY decrease of 7591.4% (in 2021) over the last 5 years.
  • Over the past 5 years, Mimedx's Amortization of Deferred Charges (Quarter) stood at $112000.0 in 2021, then rose by 6.25% to $119000.0 in 2022, then rose by 10.92% to $132000.0 in 2023, then tumbled by 47.73% to $69000.0 in 2024, then surged by 95.65% to $135000.0 in 2025.
  • Its last three reported values are $135000.0 in Q1 2025, $69000.0 for Q1 2024, and $132000.0 during Q4 2023.